Low risk of cervical cancer during a long period after negative screening in the Netherlands

Por van den Akker-van Marle, M E, van Ballegooijen, M, Habbema, J D F
Publicado em 2003

Withdrawing low risk women from cervical screening programmes : Conclusions cannot yet be drawn

Por van den Akker-van Marle, M E, van Ballegooijen, M, Boer, R, van Oortmarssen, G J, Habbema, J D F
Publicado em 1999

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.

Por van Ballegooijen, M., van den Akker-van Marle, M. E., Warmerdam, P. G., Meijer, C. J., Walboomers, J. M., Habbema, J. D.
Publicado em 1997

Implementation of a shared care guideline on the lumbosacral radicular syndrome: effects on unnecessary referrals, waiting time and costs

Por Fleuren, M.A.H., Dusseldorp, E., Van den Akker-Van Marle, M.E., Van den Bergh-Verhappen, S., Wildschut, J., Vlek, H., Wijkel, D.
Publicado em 2009

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy

Por Groenewoud, J H, Pijnappel, R M, van den Akker-van Marle, M E, Birnie, E, Buijs-van der Woude, T, Mali, W P Th M, de Koning, H J, Buskens, E
Publicado em 2004